186 related articles for article (PubMed ID: 12500695)
1. Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase.
Uchida M; Chen Z; Liu Y; Black KL
Neurol Res; 2002 Dec; 24(8):739-46. PubMed ID: 12500695
[TBL] [Abstract][Full Text] [Related]
2. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
3. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
5. Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors.
Liu Y; Hashizume K; Chen Z; Samoto K; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Jun; 23(4):379-87. PubMed ID: 11428519
[TBL] [Abstract][Full Text] [Related]
6. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
[TBL] [Abstract][Full Text] [Related]
7. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
Nomura T; Inamura T; Black KL
Brain Res; 1994 Oct; 659(1-2):62-6. PubMed ID: 7529648
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors.
Sugita M; Black KL
Cancer Res; 1998 Mar; 58(5):914-20. PubMed ID: 9500450
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
10. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Dean RL; Emerich DF; Hasler BP; Bartus RT
Neuro Oncol; 1999 Oct; 1(4):268-74. PubMed ID: 11550318
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone enhances calcium-activated potassium channel expression in blood-brain tumor barrier in a rat brain tumor model.
Gu YT; Xue YX; Wang P; Zhang H; Qin LJ; Liu LB
Brain Res; 2009 Mar; 1259():1-6. PubMed ID: 19401176
[TBL] [Abstract][Full Text] [Related]
12. Low dose of bradykinin selectively increases intracellular calcium in glioma cells.
Wang YB; Peng C; Liu YH
J Neurol Sci; 2007 Jul; 258(1-2):44-51. PubMed ID: 17382350
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway.
Liu LB; Xue YX; Liu YH
J Neurooncol; 2010 Sep; 99(2):187-94. PubMed ID: 20146088
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin increased the permeability of BTB via NOS/NO/ZONAB-mediating down-regulation of claudin-5 and occludin.
Liu LB; Liu XB; Ma J; Liu YH; Li ZQ; Ma T; Zhao XH; Xi Z; Xue YX
Biochem Biophys Res Commun; 2015 Aug; 464(1):118-25. PubMed ID: 26106824
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin-induced blood-tumor barrier opening is mediated by tumor necrosis factor-alpha.
Qin LJ; Gu YT; Zhang H; Xue YX
Neurosci Lett; 2009 Jan; 450(2):172-5. PubMed ID: 18983897
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model.
Gu YT; Zhang H; Xue YX
Brain Res; 2007 Aug; 1162():1-8. PubMed ID: 17618607
[TBL] [Abstract][Full Text] [Related]
17. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas.
Matsukado K; Sugita M; Black KL
Brain Res; 1998 May; 792(1):10-5. PubMed ID: 9593802
[TBL] [Abstract][Full Text] [Related]
18. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.
Ningaraj NS; Rao M; Hashizume K; Asotra K; Black KL
J Pharmacol Exp Ther; 2002 Jun; 301(3):838-51. PubMed ID: 12023511
[TBL] [Abstract][Full Text] [Related]
19. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
Inamura T; Nomura T; Bartus RT; Black KL
J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
[TBL] [Abstract][Full Text] [Related]
20. Induction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat model.
Côté J; Bovenzi V; Savard M; Dubuc C; Fortier A; Neugebauer W; Tremblay L; Müller-Esterl W; Tsanaclis AM; Lepage M; Fortin D; Gobeil F
PLoS One; 2012; 7(5):e37485. PubMed ID: 22629405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
